Previous Close | 66.54 |
Open | 66.85 |
Bid | 66.47 x 1100 |
Ask | 66.48 x 800 |
Day's Range | 66.35 - 67.16 |
52 Week Range | 45.76 - 68.34 |
Volume | 5,201,163 |
Avg. Volume | 10,555,366 |
Market Cap | 150.113B |
Beta (5Y Monthly) | 0.65 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.02 |
Earnings Date | Feb 04, 2021 |
Forward Dividend & Yield | 1.96 (2.97%) |
Ex-Dividend Date | Dec 31, 2020 |
1y Target Est | 74.88 |
Company's R&D aimed at cell replacement therapy for range of diseases
Bristol-Myers Squibb (BMY) closed the most recent trading day at $66.54, moving +0.79% from the previous trading session.
Wedgewood Partners recently released its Q4 2020 Investor Letter, a copy of which you can download here. The Fund returned 12.2% for the fourth quarter of 2020. Meanwhile, the benchmark S&P 500 Index and the Russell 1000 Growth Index gained 12.2% and 11.4%, respectively. You should check out Wedgewood Partners’ top 5 stock picks for […]